SACUBITRIL/VALSARTAN USE IN A REAL WORLD EXPERIENCE: DATA FROM A LARGE SINGLE-CENTER POPULATION OF HEART FAILURE PATIENTS WITH REDUCED EJECTION FRACTION

被引：0
|
作者：
Mapelli, M.
Salvioni, E.
Mattavelli, I.
Sassi, V.
Gugliandolo, P.
Mantegazza, V.
Volpato, V.
Vignati, C.
De Martino, F.
Paolillo, S.
Contini, M.
Apostolo, A.
Magini, A.
Palermo, P.
Agostoni, P.
机构：
[1] IRCCS, Ctr Cardiol Monzino, Milan, Italy
[2] Univ Federico II, Naples, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0G期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P361
引用
收藏
页码：G188 / G189
页数：2
相关论文
共 50 条
  • [31] Real-World Experience Of Sacubitril-Valsartan Combination For Heart Failure With Reduced Ejection Fraction (HFrEF): A Study From A Heart Failure Clinic In The West Of Ireland
    Donnellan, F.
    Buckley, A.
    Moran, H.
    O'Connor, T.
    Lavin, F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2018, 187 : S47 - S47
  • [32] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [33] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
  • [34] Gender differences in reverse cardiac remodeling following initiation of sacubitril/valsartan in heart failure with reduced ejection fraction: real world experience
    Savage, P. S.
    Campbell, P. C.
    Adams, S. A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 900 - 900
  • [35] Use of phenomapping to determine response of treatment by sacubitril/valsartan in patients with heart failure with reduced ejection fraction
    Godet, M.
    Raitiere, O.
    Chopra, H.
    Guignant, P.
    Fauvel, C.
    Gaudin, K.
    Eltchaninoff, H.
    Beuer, F.
    EUROPEAN HEART JOURNAL, 2019, 40 : 735 - 735
  • [36] The benefits of the earlier use of sacubitril/valsartan in de novo heart failure with reduced ejection fraction patients
    Oh, Ji-Hye
    Lee, Jae-Man
    Lee, Hee-Jung
    Hwang, Jongmin
    Lee, Cheol Hyun
    Cho, Yun-Kyeong
    Park, Hyoung-Seob
    Yoon, Hyuck-Jun
    Chung, Jin-Wook
    Kim, Hyungseop
    Nam, Chang-Wook
    Han, Seongwook
    Hur, Seung-Ho
    Youn, Jong-Chan
    Kim, In-Cheol
    ESC HEART FAILURE, 2022, 9 (04): : 2435 - 2444
  • [37] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [38] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [39] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [40] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
12345